ELANNYSE

Elanco Animal Health Inc

Healthcare·Immunology·Commercial·Indianapolis, IN, United States
ImmunologyDermatology

Elanco Animal Health Inc (ELAN): 4 pipeline candidates · ~9 mo cash runway. Updated within the last hour.

7.2/10

BioSniper Score

5-factor signal · derived from public data

Cash Runway2.4

8.6 months

Financial Health8.3

D/E 1.03 · 1% dilution

Pipeline Maturity10.0

Lead: Approved

Pipeline Breadth7.2

4 candidates

Catalyst MomentumN/A

N/A

Insider Signal8.0

2 buys · 0 sells (180d)

A transparent, data-derived signal for Elanco Animal Health Incacross cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

$12.1B

Cash

$428.0M

Quarterly Burn

$478.0M

Runway

8.6 mo

Revenue

$1.4B

Cash Runway vs Catalysts

Tracked catalysts land within the current projected cash runway.

Cash ends ~Mar 2027
Today~9 mo out
Catalyst within runway

Pipeline (4 candidates)

Institutional Holdings

Source: SEC Form 13F · as of Mar 2026

Institutional holders

512

Total value held

$12.30B

HolderSharesValue
dodge & cox68,944,100$1.65B
fmr llc50,925,366$1.22B
blackrock, inc.47,622,630$1.14B
primecap management co/ca/45,840,956$1.10B
vanguard capital management llc44,672,248$1.07B
dimensional fund advisors lp24,527,135$586.9M
vanguard portfolio management llc22,637,357$541.7M
state street corp15,336,479$367.0M
geode capital management, llc11,192,404$267.9M
black creek investment management inc.10,493,849$251.1M

Showing top 10 of 512 institutional holders of Elanco Animal Health Inc. Sign up for the full 13F holder list and quarter-by-quarter ownership history.

·CEO: Mr. Jeffrey N. Simmons

Frequently asked questions

How many drug candidates are in Elanco Animal Health Inc's pipeline?

Elanco Animal Health Inc (ELAN) has 4 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.

What is Elanco Animal Health Inc's lead drug candidate?

Elanco Animal Health Inc's most advanced tracked candidate is bovaer (Approved) for Methane reduction in lactating dairy cattle.

What is Elanco Animal Health Inc's cash runway?

Based on its most recent reported cash balance and quarterly burn rate, Elanco Animal Health Inc has approximately 8.6 months of cash runway.

What is Elanco Animal Health Inc's market capitalization?

Elanco Animal Health Inc's market capitalization is approximately $12.1B.

Who is the CEO of Elanco Animal Health Inc?

Mr. Jeffrey N. Simmons is the chief executive officer of Elanco Animal Health Inc (ELAN).

Get the full picture on Elanco Animal Health Inc

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.